Unknown PHASE2 INTERVENTIONAL NCT00024336

Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

Treatment of Children With Newly Diagnosed Diffuse Pontine Gliomas Using Conventional Radiotherapy and High Dose Tamoxifen

Sponsor: Children's Cancer and Leukaemia Group

Conditions Brain and Central Nervous System Tumors

Interventions radiation therapy tamoxifen citrate

Updated 6 times since 2017 Last updated: Aug 6, 2013 Started: Aug 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Brain and Central Nervous System Tumors and is currently ongoing. Children's Cancer and Leukaemia Group leads this study, which shows 6 recorded versions since 1999 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Aug 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Cancer and Leukaemia Group

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aberdeen, United Kingdom , Belfast, United Kingdom , Birmingham, United Kingdom , Bristol, United Kingdom , Cambridge, United Kingdom , Crumlin, Ireland , Edinburgh, United Kingdom , Glasgow, United Kingdom , Leeds, United Kingdom , Leicester, United Kingdom and 10 more locations